Literature DB >> 12115533

A population-based familial aggregation analysis indicates genetic contribution in a majority of renal cell carcinomas.

Tómas Gudbjartsson1, Thora J Jónasdóttir, Asgeir Thoroddsen, Gudmundur V Einarsson, Gudrún M Jónsdóttir, Kristleifur Kristjánsson, Sverrir Hardarson, Kjartan Magnússon, Jeffrey Gulcher, Kári Stefánsson, Laufey T Amundadóttir.   

Abstract

The etiology of RCC is incompletely understood and the inherited genetic contribution uncertain. Although there are rare mendelian forms of RCC stemming from inherited mutations, most cases are thought to be sporadic. We sought to determine the extent of familial aggregation among Icelandic RCC patients in general. Medical and pathologic records for all patients diagnosed with RCC in Iceland between 1955 and 1999 were reviewed. This included a total of 1,078 RCC cases, 660 males and 418 females. With the use of an extensive computerized database containing genealogic information on 630,000 people in Iceland during the past 11 centuries, several analyses were conducted to determine whether the patients were more related to each other than members drawn at random from the population. Patients with RCC were significantly more related to each other than were subjects in matched groups of controls. This relatedness extended beyond the nuclear family. RRs were significantly greater than 1.0 for siblings, parents and cousins of probands. RRs were 2-3 for first-degree relatives and 1.6 for third-degree relatives. The risk of RCC is significantly higher for members of the extended family of an affected individual, as well as the nuclear family. Our results indicate that germline mutations are significantly involved in what has been defined as sporadic RCC. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12115533     DOI: 10.1002/ijc.10513

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

1.  Family history and risk of renal cell carcinoma: results from a case-control study and systematic meta-analysis.

Authors:  Jessica Clague; Jie Lin; Adrian Cassidy; Surena Matin; Nizar M Tannir; Pheroze Tamboli; Christopher G Wood; Xifeng Wu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-24       Impact factor: 4.254

Review 2.  Renal cell carcinoma.

Authors:  James J Hsieh; Mark P Purdue; Sabina Signoretti; Charles Swanton; Laurence Albiges; Manuela Schmidinger; Daniel Y Heng; James Larkin; Vincenzo Ficarra
Journal:  Nat Rev Dis Primers       Date:  2017-03-09       Impact factor: 52.329

3.  Non-Familial Synchronous Bilateral Renal Cell Carcinoma with Bilateral Synchronous Renal Vein Extension and Inferior Vena Cava Thrombus.

Authors:  Wilson Lin; Kara L Watts; Meenakshi Davuluri; Ahmed Aboumohamed
Journal:  Curr Urol       Date:  2019-09-10

Review 4.  Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention.

Authors:  Steffen Weikert; Börje Ljungberg
Journal:  World J Urol       Date:  2010-06       Impact factor: 4.226

Review 5.  Hereditary renal cell carcinoma: genetics, clinical features, and surgical considerations.

Authors:  Timothy K Byler; Gennady Bratslavsky
Journal:  World J Urol       Date:  2014-04-08       Impact factor: 4.226

6.  Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma.

Authors:  Maria I Carlo; Semanti Mukherjee; Diana Mandelker; Joseph Vijai; Yelena Kemel; Liying Zhang; Andrea Knezevic; Sujata Patil; Ozge Ceyhan-Birsoy; Kuo-Cheng Huang; Almedina Redzematovic; Devyn T Coskey; Carolyn Stewart; Nisha Pradhan; Angela G Arnold; A Ari Hakimi; Ying-Bei Chen; Jonathan A Coleman; David M Hyman; Marc Ladanyi; Karen A Cadoo; Michael F Walsh; Zsofia K Stadler; Chung-Han Lee; Darren R Feldman; Martin H Voss; Mark Robson; Robert J Motzer; Kenneth Offit
Journal:  JAMA Oncol       Date:  2018-09-01       Impact factor: 31.777

Review 7.  Renal cell cancers: unveiling the hereditary ones and saving lives-a tailored diagnostic approach.

Authors:  Georgios Kallinikas; Helai Habib; Dimitrios Tsimiliotis; Evangelos Koutsokostas; Barna Bokor
Journal:  Int Urol Nephrol       Date:  2017-05-31       Impact factor: 2.370

8.  Family history of cancer and renal cell cancer risk in Caucasians and African Americans.

Authors:  S Karami; K Schwartz; M P Purdue; F G Davis; J J Ruterbusch; S S Munuo; S Wacholder; B I Graubard; J S Colt; W-H Chow
Journal:  Br J Cancer       Date:  2010-05-04       Impact factor: 7.640

Review 9.  Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy.

Authors:  Elizabeth Cartwright Pfaffenroth; W Marston Linehan
Journal:  Expert Opin Biol Ther       Date:  2008-06       Impact factor: 4.388

10.  Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer.

Authors:  Brian Shuch; Christopher J Ricketts; Cathy D Vocke; Takefumi Komiya; Lindsay A Middelton; Eric C Kauffman; Maria J Merino; Adam R Metwalli; Phillip Dennis; W Marston Linehan
Journal:  J Urol       Date:  2013-06-11       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.